{
  "docId": "019de073-c7d4-73ef-8fef-22f9b5017668",
  "docSlug": "c95aa30aee69a466f8f903e1480a3b33",
  "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 32 slides",
  "authorId": "larimar-therapeutics",
  "authorName": "Larimar Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 29,
  "pageCount": 32,
  "prevPage": 28,
  "nextPage": 30,
  "slideType": "traction",
  "function": "show_traction",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a bulleted list with checkmarks to summarize key findings from a specific mouse model study.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-c7d4-73ef-8fef-22f9b5017668/29",
  "deckHref": "/decks/019de073-c7d4-73ef-8fef-22f9b5017668",
  "deckJsonHref": "/decks/019de073-c7d4-73ef-8fef-22f9b5017668.json",
  "deckAnchorHref": "/decks/019de073-c7d4-73ef-8fef-22f9b5017668#slide-29",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.55,
        "x": 0.38,
        "y": 0.5
      },
      "kind": "list",
      "text": "hFXN replacement with CTI-1601 prevents the development of ataxic gait\nCTI-1601-treated mice survive longer than untreated mice\nHuman frataxin present in brain, dorsal root ganglia and spinal cord demonstrating central nervous system penetration",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd1251a1-e1b6-4684-a4cb-fb50bb5433b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.38,
        "y": 0.3
      },
      "kind": "paragraph",
      "text": "Pvalb-Cre FXN-KO mouse\nSingle dose level: 10 mg/kg CTI-1601 or vehicle given intraperitoneally three times per week",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fa17dc6-ad75-4be2-a10e-c417a95f1ee3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.05,
        "y": 0.68
      },
      "kind": "paragraph",
      "text": "In-Vivo Efficacy Data in Neurologic KO Mouse Model",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff752d9f-d54d-4cae-ad39-bf777770adb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "title",
      "text": "CTI-1601 Prevents The Development of Ataxic Gait in KO mice",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8856119f-3031-44ca-ae07-788fb5758d40",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "b4c6b834-4847-48a3-8dcc-edf239287532",
      "evidence": "The slide contains a list of bullet points highlighting the results of mouse model studies.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}